Search research articles
Contact Us
Filters
Showing results (1-10 of 50) with videos related to
Page
of 5
Sort By:
Advances in Clinical Neuroscience & Rehabilitation : ACNR
|
October 26, 2020
Hallucinations in Parkinson's disease: new insights into mechanisms and treatments
Rimona S Weil, Suzanne Reeves
Neurology
|
February 11, 2009
Increased striatal dopamine (D2/D3) receptor availability and delusions in Alzheimer disease
Suzanne Reeves, Richard Brown, Robert Howard, et al.
Journal of Psychosocial Nursing and Mental Health Services
|
October 10, 2017
Very Late-Onset Schizophrenia-Like Psychosis: A Clinical Update
Elizabeth Cort, Jennifer Meehan, Suzanne Reeves, et al.
International Journal of Geriatric Psychiatry
|
July 26, 2017
Reduced parahippocampal volume and psychosis symptoms in Alzheimer's disease
Emma McLachlan, Jennifer Bousfield, Robert Howard, et al.
Journal of Alzheimer'S Disease : JAD
|
October 26, 2020
The Relationship Between Anxiety and Incident Agitation in Alzheimer's Disease
Kathy Y Liu, Harry Costello, Suzanne Reeves, et al.
Journal of Clinical Psychopharmacology
|
June 2, 2022
Plasma Clozapine and Norclozapine After Use of Either Crushed Tablets or Suspension Compared With Tablets
Robert James Flanagan, Samora Hunter, Stephen John Obee, et al.
JAMA Psychiatry
|
May 24, 2023
Association Between False Memories and Delusions in Alzheimer Disease
Emma McLachlan, Dilek Ocal, Neil Burgess, et al.
Neurobiology of Disease
|
November 17, 2009
The dopaminergic basis of cognitive and motor performance in Alzheimer's disease
Suzanne Reeves, Mitul Mehta, Robert Howard, et al.
Journal of Clinical Psychopharmacology
|
February 3, 2023
Clozapine: Dose, Sex, Ethnicity, Smoking Habit, Age, Body Weight, and Plasma Clozapine and N -Desmethylclozapine (Norclozapine) Concentrations in Clinical Practice
Robert James Flanagan, Samora Hunter, Stephen John Obee, et al.
British Journal of Clinical Pharmacology
|
February 15, 2023
Guiding safer risperidone prescribing in Alzheimer's disease with therapeutic drug monitoring
Matthew Roughley, Carlos Mena, Robert Howard, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 50) with videos related to
Sort By:
Page
of 5
Advances in Clinical Neuroscience & Rehabilitation : ACNR
|
October 26, 2020
Hallucinations in Parkinson's disease: new insights into mechanisms and treatments
Rimona S Weil, Suzanne Reeves
Neurology
|
February 11, 2009
Increased striatal dopamine (D2/D3) receptor availability and delusions in Alzheimer disease
Suzanne Reeves, Richard Brown, Robert Howard, et al.
Journal of Psychosocial Nursing and Mental Health Services
|
October 10, 2017
Very Late-Onset Schizophrenia-Like Psychosis: A Clinical Update
Elizabeth Cort, Jennifer Meehan, Suzanne Reeves, et al.
International Journal of Geriatric Psychiatry
|
July 26, 2017
Reduced parahippocampal volume and psychosis symptoms in Alzheimer's disease
Emma McLachlan, Jennifer Bousfield, Robert Howard, et al.
Journal of Alzheimer'S Disease : JAD
|
October 26, 2020
The Relationship Between Anxiety and Incident Agitation in Alzheimer's Disease
Kathy Y Liu, Harry Costello, Suzanne Reeves, et al.
Journal of Clinical Psychopharmacology
|
June 2, 2022
Plasma Clozapine and Norclozapine After Use of Either Crushed Tablets or Suspension Compared With Tablets
Robert James Flanagan, Samora Hunter, Stephen John Obee, et al.
JAMA Psychiatry
|
May 24, 2023
Association Between False Memories and Delusions in Alzheimer Disease
Emma McLachlan, Dilek Ocal, Neil Burgess, et al.
Neurobiology of Disease
|
November 17, 2009
The dopaminergic basis of cognitive and motor performance in Alzheimer's disease
Suzanne Reeves, Mitul Mehta, Robert Howard, et al.
Journal of Clinical Psychopharmacology
|
February 3, 2023
Clozapine: Dose, Sex, Ethnicity, Smoking Habit, Age, Body Weight, and Plasma Clozapine and N -Desmethylclozapine (Norclozapine) Concentrations in Clinical Practice
Robert James Flanagan, Samora Hunter, Stephen John Obee, et al.
British Journal of Clinical Pharmacology
|
February 15, 2023
Guiding safer risperidone prescribing in Alzheimer's disease with therapeutic drug monitoring
Matthew Roughley, Carlos Mena, Robert Howard, et al.
Page
of 5